この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/10/141 分で読めます
National Cancer Institute; Opportunity for a Cooperative Research Agreement (CRADA) for the Clinical Evaluation of Magnetic Resonance Imaging in Breast Cancer
ローカル自動翻訳 · 情報源の原言語
概要
The National Cancer Institute (NCI) seeks major pharmaceutical companies that can effectively pursue the joint research, development, evaluation and commercialization of imaging drugs to be used for magnetic resonance imaging (MRI) in breast cancer. NCI will enter into CRADA negotiations with the sponsor(s) of the selected proposal(s).
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →